Cargando…
The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
With the expiration of biologics’ patents, biosimilars entered the market as a promising opportunity to reduce health-care costs in the field of inflammatory bowel diseases. Although biosimilars were initially poorly accepted, the growing evidence about their efficacy and safety has changed this sit...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927805/ https://www.ncbi.nlm.nih.gov/pubmed/36798960 http://dx.doi.org/10.1093/crocol/otab012 |